News Medivation in merger talks with Sanofi and others Sources say Pfizer and Celgene are also interested.
News BIND accepts Pfizer bid following bankruptcy Bid of $20 million may be enough to acquire all of BIND's assets.
News Pfizer cholesterol drug succeeds in two late stage trials Pfizer's bococizumab cholesterol drug has met primary endpoint in two phase 3 trials, part of a series of six late-stage studies.
News Shire buys rights to Pfizer gastrointestinal drug Shire has bought rights to PF-00547659 for an undisclosed sum.
News Pfizer's antibody drug trial misses key survival target in A... Inotuzumab ozogamicin missed one of two endpoints in trial.
News Pfizer to work with IBM on Parkinson’s disease wearable American pharma giant Pfizer has enlisted the help of technology multinational IBM in an ambitious bid to transform both care and treatment for Parkinson's disease.
News Australia starts probe into AI infiltration of Medicare The infiltration of Australia's Medicare by an AI agent raises serious questions about patient privacy and the security of confidential pharma data.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
